Simon Douglas

Simon Douglas

Net worth: 112 980 $ as of 31/07/2026

68 year
Health Technology
Commercial Services
Consumer Services

Profile

Dr. Simon G.
Douglas is a Chairman at EMQN CIC, a Non-Executive Chairman at C-Major Ltd. and a Non-Executive Chairman at Fusion Antibodies Plc.
Dr. Douglas was previously employed as a Non-Executive Chairman by Abselion Ltd., a Non-Executive Chairman by Cambridge Nutritional Sciences Plc, a Chief Executive Officer & Director by Biofortuna Ltd., an Executive Chairman by Lab901 Ltd., a Managing Director by Invitrogen Holdings Ltd., a Chief Executive Officer by DNA Research Innovations Ltd., a Chief Executive Officer by DRI Ltd. (United Kingdom), a Chief Executive Officer by Tepnel Life Sciences Plc, a Head-Technical & Marketing by ICI Group, a Project Leader by GE Healthcare Ltd. (United Kingdom), and a Manager-Business Development by Zeneca, Inc. He received his graduate degree from The University of Southampton and a doctorate degree from The University of Southampton.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
17/02/2026 8,61,062 ( 0.69% ) 112 980 $ 31/07/2026

Simon Douglas active positions

CompaniesPositionStart
FUSION ANTIBODIES PLC Chairman 01/09/2011
Chairman 01/09/2019

Former positions of Simon Douglas

CompaniesPositionEnd
Chairman 23/03/2026
CAMBRIDGE NUTRITIONAL SCIENCES PLC Chairman 22/04/2024
Chief Executive Officer 01/01/2019
Chairman 01/01/2011
Chief Executive Officer 01/01/2006
See the detail of Simon Douglas's experience

Training of Simon Douglas

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

25

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

Process Industries

Zeneca, Inc.

Health Services

Finance

Commercial Services

Technology Services

Health Technology

DRI Ltd. (United Kingdom)